Analysis Of Status Quo And Influencing Factors Of Demoralization Syndrome In Patients With Gynecological Malignant Tumor Undergoing Chemotherapy

ObjectiveTo investigate the current status of demoralization syndrome in chemotherapy patients with gynecological malignancies.The main factors affecting demoralization syndrome in chemotherapy patients with gynecological malignant tumors were analyzed.This paper provided ideas and a basis for further constructing personalized psychological nursing programs for chemotherapy patients with gynecological malignant tumors and reducing the incidence of demoralization syndrome.MethodsThis study is a cross-sectional study,Using the convenient sampling method.171 patients with gynecological malignant tumors who met the standards of that row in the department of gynecology and urogenital oncology of a tertiary hospital in Dalian from December 2021 to June 2022 were selected as the survey objects.The general information questionnaire,the second edition of the Demoralization ScaleⅡ,Medical Coping Modes Questionnaire,Chinese Mandarin version of the Medical Outcomes Study Social Support Survey and The Brief Illness Perception Questionnaire were used to investigate.The data were entered by two people,and SPSS 25.0 software was used to sort out and analyze the data.The counting data were described by frequency and percentage(%);If the measurement data conform to the normal distribution,use the mean±standard deviation(X±s)to describe;The data of non normal distribution are described by median and inter quartile interval,which meet the normal distribution and have the same variance using independent sample t test;Analysis of variance was used for comparison among groups;Non parametric rank sum test was used to analyze the relationship between coping style,medical social support,disease perception and demoralization syndrome in patients with gynecological malignant tumor undergoing chemotherapy by Pearson,and the influencing factors of demoralization syndrome in patients with gynecological malignant tumor undergoing chemotherapy were analyzed by multiple linear stepwise regression.The difference was statistically significant(P<0.05).Results1.A total of 171 questionnaires were distributed and collected in the survey,with the collection rate of 100%.Among them,171 valid questionnaires were returned,with a recovery rate of 100%.2.In this study,95 patients(55.6%)with gynecologic malignant tumor chemotherapy without demoralization syndrome and 76 patients(44.4%)with demoralization syndrome were treated with chemotherapy.The score of demoralization syndrome in patients with gynecological malignant tumor undergoing chemotherapy ranged from(1 28),with an average score of(9.70±5.06).Total score and scores of each dimension: the stress and coping dimensions scored the highest(6.33±2.52),followed by the meaning and goal dimensions(3.04±2.31).3.The results of single factor analysis showed that the levels of demoralization syndrome in patients with gynecologic malignant tumor undergoing chemotherapy were different due to different educational level,religious belief,whether they have children,family residence,per capita monthly income of families,medical payment method,diagnosis duration,whether they have metastasis,and clinical staging,and the differences were statistically significant(p<0.05).4.Pearson correlation analysis showed that the total score of the second edition of the scale of demoralization syndrome was positively correlated with medical coping(r=0.217,p<0.01).The total score of the second edition of the scale of demoralization syndrome was negatively correlated with medical and social support(r=-0.409,p<0.01).There was a significant positive correlation between the total score of the second edition of the scale of demoralization syndrome and disease perception(r=0.567,p<0.01).5.The results of multiple linear stepwise regression showed that education level,childlessness,medical coping,facing dimension,avoiding dimension,yielding dimension,medical and social support,and disease perception of patients with gynecological malignant tumor undergoing chemotherapy were the influencing factors of demoralization syndrome(R2=0.508,R2=0.446 after adjustment,F=8.197,P<0.001),which explained 44.6% of the total variation of demoralization syndrome in patients with gynecological malignant tumor undergoing chemotherapy.Conclusion1.The incidence of demoralization syndrome patients with gynecological malignancies undergoing chemotherapy is 44.4%,and the demoralization syndrome is at a medium to high level,which seriously endangers the physical and mental health of patients.There are negative responses and high disease perception,which need to be improved.2.Demoralization syndrome in patients with gynecological malignant tumor undergoing chemotherapy was significantly positively correlated with medical coping style and disease perception,and was significantly negatively correlated with social support.Improving the patient’s coping style,disease perception,and improving the patient’s social support system will help reduce the level of patients’ loss of will.3.The influencing factors of demoralization syndrome in patients with gynecological malignant tumor undergoing chemotherapy include: education level,having children or not,coping style,social support,and disease perception.4.Medical staff should focus on chemotherapy patients with gynecological malignancies who have low education,no children,negative coping styles,lack of social support,and high disease perception,and consider reducing the number of patients from the perspectives of coping strategies,disease cognition,and humanistic care.Effective strategies for the occurrence of demoralization syndrome,which can help to increase the level of hope and subjective well-being,and alleviate feelings of social alienation and isolation.